MIVACRON / MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER — FDA application NDA020098

Application NDA020098 · type NDA · FDA status: approved · original approval 1992-01-22

Listed sponsor: ABBVIE · ABBV company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

Product	FDA-listed trade name	Active ingredient	Dosage form	Route	Strength	Marketing status	TE code	RLD
001	MIVACRON	MIVACURIUM CHLORIDE	SOLUTION	INTRAVENOUS	EQ 2MG BASE/ML (EQ 2MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Discontinued	not listed	Yes
002	MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER	MIVACURIUM CHLORIDE	INJECTABLE	INJECTION	EQ 0.5MG BASE/ML	Discontinued	not listed	No
003	MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER	MIVACURIUM CHLORIDE	INJECTABLE	INJECTION	EQ 50MG BASE/100ML	Discontinued	not listed	No
004	MIVACRON	MIVACURIUM CHLORIDE	SOLUTION	INTRAVENOUS	EQ 10MG BASE/5ML (EQ 2MG BASE/ML)	Discontinued	not listed	Yes
005	MIVACRON	MIVACURIUM CHLORIDE	SOLUTION	INTRAVENOUS	EQ 20MG BASE/10ML (EQ 2MG BASE/ML)	Discontinued	not listed	Yes

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

No Orange Book patent or exclusivity listings joined to this application.

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.